Development and evaluation of a multidisciplinary medication management program in long-term care facility residents
- Conditions
- Not Applicable
- Registration Number
- KCT0008157
- Lead Sponsor
- Chung-Ang University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 1672
(1) 65 years of age or older;
(2) A person who meets under one or more of the following
- New residents who have been admitted to long-term care facilities within 4 to 6 weeks
- Patients who have been discharged within 1 month prior to the date of visit
- Those who have experienced a fall or fracture within 3 months prior to the date of visit
- Long-term care level 1
- Those who take more than 10 multi-drugs, excluding pRNs when needed
- Those who take medicines of concern for misuse (e.g., narcotic painkillers, inhalers, etc.)
- Those who take drugs with a narrow margin of safety or high-risk drugs (e.g., narcotic analgesics, antiepileptics, digoxin, theophylline, immunosuppressants, anticancer drugs, anticoagulants, insulin, benzodiazepines, etc.)
- Those who have experienced suspected drug side effects before or during admission to a long-term care facility
- Requesters for doctors, nurses, pharmacists, and caregivers
(1) Those who are quarantined due to an infectious disease
(2) In case of receiving regular drug prescription at a tertiary general hospital (long-term prescription for more than 90 days, the risk of potentially inappropriate drug occurrence is relatively low)
(3) If the life expectancy is predicted to be less than 6 months by a doctor or nurse (terminal cancer, etc.)
Study & Design
- Study Type
- Interventional Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Adverse drug reactions, number/number/rate of potentially inappropriate drugs, number/rate of users of two or more CNS contractiles, delirium, number of emergency room visits, hospitalizations, and falls
- Secondary Outcome Measures
Name Time Method umber of medications taken, number/rate of polypharmacy users